Cargando…
Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
Cyclo-oxygenase (COX) inhibitors are among the most commonly used drugs in the western world for their anti-inflammatory and analgesic effects. However, they are also well-known to increase the risk of coronary events. This area is of renewed significance given alarming new evidence suggesting this...
Autores principales: | Khan, Shanzana, Andrews, Karen L., Chin-Dusting, Jaye P. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747368/ https://www.ncbi.nlm.nih.gov/pubmed/31480335 http://dx.doi.org/10.3390/ijms20174262 |
Ejemplares similares
-
Y Chromosome, Hypertension and Cardiovascular Disease: Is Inflammation the Answer?
por: Khan, Shanzana I., et al.
Publicado: (2019) -
Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
por: Moore, R Andrew, et al.
Publicado: (2007) -
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors
por: Ahmadi, Mohsen, et al.
Publicado: (2022) -
Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders
por: Ryter, Stefan W.
Publicado: (2022) -
The importance of provocation tests with COX2 inhibitors on patients with a history of cross-hypersensitivity to non-steroidal anti-inflammatory (NSAIDs)
por: Gonçalves, Tania Tavares
Publicado: (2015)